Convergence Investment Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$737K	Buy	+2,259	New	+$737K	0.19%	170
2024 Q4	–	Sell	-1,513	Closed	-$416K	–	254
2024 Q3	$416K	Buy	+1,513	New	+$416K	0.11%	184